58 related articles for article (PubMed ID: 1375006)
1. Inflammatory cells and mediator release during ragweed challenge: correlation between histamine content in nasal secretions and appearance of inflammatory cells.
Georgitis JW; Stone BD; Gottschlich G
Ann Allergy; 1992 May; 68(5):413-8. PubMed ID: 1375006
[TBL] [Abstract][Full Text] [Related]
2. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions.
Georgitis JW; Stone BD; Gottschlich G
Int Arch Allergy Appl Immunol; 1991; 96(3):231-7. PubMed ID: 1666629
[TBL] [Abstract][Full Text] [Related]
3. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
4. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils.
Iliopoulos O; Baroody FM; Naclerio RM; Bochner BS; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1992 Apr; 148(7):2223-8. PubMed ID: 1372025
[TBL] [Abstract][Full Text] [Related]
5. Nasal challenge with allergen leads to maxillary sinus inflammation.
Baroody FM; Mucha SM; Detineo M; Naclerio RM
J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
7. Effects of intensity of early response to allergen on the late phase of both the nose and skin.
Small P; Biskin N; Barrett D
Ann Allergy; 1994 Sep; 73(3):252-8. PubMed ID: 8092561
[TBL] [Abstract][Full Text] [Related]
8. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
Wagenmann M; Schumacher L; Bachert C
Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
10. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.
Charlesworth EN; Kagey-Sobotka A; Schleimer RP; Norman PS; Lichtenstein LM
J Immunol; 1991 Jan; 146(2):671-6. PubMed ID: 1702812
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
12. [Mediators of immunologic inflammation of the respiratory tract].
Miadonna A; Tedeschi A
Boll Ist Sieroter Milan; 1988; 67(5-6):369-76. PubMed ID: 3155333
[TBL] [Abstract][Full Text] [Related]
13. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
Kowalski ML; Grzegorczyk J; Wojciechowska B; Poniatowska M
Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
[TBL] [Abstract][Full Text] [Related]
14. Challenge with environmental tobacco smoke exacerbates allergic airway disease in human beings.
Diaz-Sanchez D; Rumold R; Gong H
J Allergy Clin Immunol; 2006 Aug; 118(2):441-6. PubMed ID: 16890770
[TBL] [Abstract][Full Text] [Related]
15. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern.
Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
J Immunol; 1997 Mar; 158(5):2406-13. PubMed ID: 9036991
[TBL] [Abstract][Full Text] [Related]
16. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.
Bascom R; Pipkorn U; Lichtenstein LM; Naclerio RM
Am Rev Respir Dis; 1988 Aug; 138(2):406-12. PubMed ID: 3195836
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
Iliopoulos O; Proud D; Adkinson NF; Creticos PS; Norman PS; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1991 Apr; 87(4):855-66. PubMed ID: 2013680
[TBL] [Abstract][Full Text] [Related]
18. Drug effects on antigen-induced release of high molecular weight-neutrophil chemotactic activity and histamine in nasal secretion from children with allergic rhinitis.
Onda T; Nagakura T; Uekusa T; Masaki T; Iikura Y
Allergy Proc; 1990; 11(5):235-40. PubMed ID: 1701746
[TBL] [Abstract][Full Text] [Related]
19. Mediator release after nasal airway challenge with allergen.
Naclerio RM; Meier HL; Kagey-Sobotka A; Adkinson NF; Meyers DA; Norman PS; Lichtenstein LM
Am Rev Respir Dis; 1983 Oct; 128(4):597-602. PubMed ID: 6354022
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.
Charlesworth EN; Hood AF; Soter NA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Clin Invest; 1989 May; 83(5):1519-26. PubMed ID: 2468688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
